Literature DB >> 3071586

Association of high plasma prorenin with diabetic retinopathy.

A A Franken1, F H Derkx, M A Schalekamp, A J Man in t'Veld, W C Hop, E H van Rens, P T de Jong.   

Abstract

Plasma prorenin, but not renin, is elevated in long-standing diabetes mellitus. Nephropathy and autonomic neuropathy have been implicated as causes. However, we found no arteriovenous difference in prorenin across the kidney, despite high levels of circulating prorenin and a very low renal plasma flow, in five diabetics with combined end-stage nephropathy and proliferative diabetic retinopathy. Moreover, plasma prorenin was normal in 16 non-diabetics with autonomic neuropathy. The presence of a high level of prorenin was closely associated with the presence of diabetic retinopathy, particularly the proliferative type, in 223 consecutive patients. This association was independent of insulin requirements, metabolic control and of the presence of nephropathy or neuropathy. These data are evidence that part of the elevated plasma prorenin in diabetics is produced by an extrarenal source and that perhaps the eye affected by diabetic retinopathy is that source.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3071586     DOI: 10.1097/00004872-198812040-00145

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  7 in total

1.  Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay.

Authors:  H Yokota; F Mori; K Kai; T Nagaoka; N Izumi; A Takahashi; T Hikichi; A Yoshida; F Suzuki; Y Ishida
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Raised plasma renin and prorenin in rheumatoid vasculitis.

Authors:  M Boers; F C Breedveld; B A Dijkmans; P C Chang; P van Brummelen; F H Derkx; A Cats
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

3.  Effect of Adding Losartan to Bevacizumab for Treating Diabetic Macular Edema.

Authors:  Fariba Ghassemi; Abdulrahim Amini; Masoud Yasemi; Amin Nabavi; Mohammadkarim Johari
Journal:  J Ophthalmol       Date:  2020-10-01       Impact factor: 1.909

4.  Oral kallidinogenase improved visual acuity and maintained chorioretinal blood flow levels after treatment for diabetic macular edema.

Authors:  Eiko Tsuiki; Kiyoshi Suzuma; Makiko Matsumoto; Yasser Helmy Mohamed; Takashi Kitaoka
Journal:  Clin Ophthalmol       Date:  2018-09-21

5.  α-Ketoglutarate Upregulates Collecting Duct (Pro)renin Receptor Expression, Tubular Angiotensin II Formation, and Na+ Reabsorption During High Glucose Conditions.

Authors:  Aarón Guerrero; Bruna Visniauskas; Pilar Cárdenas; Stefanny M Figueroa; Jorge Vivanco; Nicolas Salinas-Parra; Patricio Araos; Quynh My Nguyen; Modar Kassan; Cristián A Amador; Minolfa C Prieto; Alexis A Gonzalez
Journal:  Front Cardiovasc Med       Date:  2021-06-04

6.  FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.

Authors:  Devy Deliyanti; Yuan Zhang; Fay Khong; David R Berka; David I Stapleton; Darren J Kelly; Jennifer L Wilkinson-Berka
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

7.  Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.

Authors:  Wendy W Batenburg; Amrisha Verma; Yunyang Wang; Ping Zhu; Mieke van den Heuvel; Richard van Veghel; A H Jan Danser; Qiuhong Li
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.